Member Info for CHELSEA7

Well you sure sound stroppy to me!!! And your use of CAPITALS , lol.

I have seen you mention the IND a few times now since I first mentioned it, but you still ask......."".You have "mentioned it a few times now". So you have - on what grounds may I ask?""

Well if you read the post before I gave a couple of reasons why I think it is worth an opinion, why do you use it???

TF, as i posted.................

."" It is just my opinion but I do think we are close to being able to reapply for the IND to the FDA,"".............and I have mentioned it a few times now. Something must be happening and I don"t think we are pursuing other trial sites with all that is involved in the cost of Keytruda being met. So we are pending a news update of the status of the trial, and I believe it is a very strong possibility that the U.S.A is still on. There certainly has been time for Ichor to sort out any issues with the FDA.

Really cannot imagine any bigger Pharma putting a platform, which produced such good data, on hold when the vaccine has been manufactured and paid for already and is recruiting patients as we speak. It is just my opinion but I do think we are close to being able to reapply for the IND to the FDA, and until that is finalised we just cannot get even an update on where we stand, as is the case ATM.

As I said before I wouldn"t attempt to interpret what DE gave as an example, we don"t even know the conversation that had been taking place prior to him saying that or in what context, but shelving SCIB1?? Cannot see how that makes any sense.

For 81k, just my opion but getting ready for bounce and RNS next week.

Taking 50k at 6p.

Volume 143k................4 sells

At 6p, looks like that 5.80/6.20 could be coming.

Agree totally

Berm/Loch,

If you had 6 patients being treated by SCIB1 and all patients were supplementing treatment with othere remedies, by definition how can you compare the data with any certainty that results are down to the treatment for the trial intended. Hope that helps.

With regard to being precluded, the NHS system here works on signing a five year contract (unless it has changed recently) where you are guaranteed to be treated but not if you are taking any other non hospital approved products i.e homeopathic remedies. The mindset is they will not be responsible for side effects that could happen nor negate the benefits of treatment they give. So yes, I would have thought that would definately be precluded.

Taking just 100k now at 6p

Two sells 24k and our daily 50k at 6.044.

Wonder how many our buyer will take today, ?

Agree totally

Taking in excess of 220k at 6.044, same as close last night.

Morning Ruck,

I rather gathered that was what you were doing, I actually felt both posts had merit, but..............??

Morning All/TF

Yes I have seen and heard a few opinions on the matters in hand. They normally all differ to some extent. For my own I do feel a new IND for the FDA is on the cards, and that being the case is not something the BOD will discuss at this stage, but pleased to see you too are open to such a way forward.

I have actually started to go back on to Davids posts over on ADVFN, speaking with him for just under an hour was so informative /interesting and I remember saying to Bermuda I would not give my opinion on what he says as you have done in the last paragraph purely because it is so easy to interpret someones meaning and would leave him having to correct posts unduly.

What came over to me was he wanted to put a few things that had been said right, as simple as that in a company he still has faith in hence his share purchase. Shelving the SCIB programme IMHO will be a big mistake. but only the BOD and any interested parties would know if that was a good commercial decision by way of preference to any other project, but the messages sent by Vulpes with their recent addition to their holding are many and I do thimk we will get updated news alomg with the Interims which will be good for all of us. As I have said many times Vulpes know more than any of us.

Ruck some very harsh comments, although your observation on BioNTech was the same as mine on first reading it.............

""Crumbs, I’m sure professor Durrant would not want to give her baby away but she is not in a position to do so. At least she has the option of leaving and discovering something else. And when she is ready to commercialise it may pick her business partners more carefully.""

We all have the same option of leaving, finding something else, and I do think as I have always said Vulpes were/are an excellent choice and addition to the BOD for their skill sets. They have only been with us for 7/8 months, further topping up in the markey justa few weeks ago, perhaps it will be fair to see in the updates how much progress is being made. Just makes me wonder given the lack of confidence expressed here why so many are still with us rather than taking the option we all have of moving on. Time will tell.................and still that stands.

And not too long to wait. Interims due and pretty sure with it will come a positive update.

Seems we are heading for 5.80/6.20, buyers and sellers around 6p could well lead to a bounce with a good update.

GN

You forget Rat, M won the Pick 3 twice this year using my numbers!!! 750/1500

Lol, another 50k sell at 6p??? MMs still taking in excess of 220k at 6.044.

Wonder why the two sells are at 6p when H/L are offering 6.044??

Trades to come..................

Lol, 100k BUY at 6.20